Breaking News Instant updates and real-time market news.

CBAY

CymaBay

$6.00

-5.08 (-45.85%)

16:09
06/11/19
06/11
16:09
06/11/19
16:09

CymaBay upgraded to Strong Buy from Outperform at Raymond James

Raymond James analyst Steven Seedhouse upgraded CymaBay to Strong Buy from Outperform citing the upside potential he sees following today's pullback in the stock. He keeps a $19 price target on the shares, calling today's reaction to the surrogate endpoint data "overblown."

  • 12

    Jun

CBAY CymaBay
$6.00

-5.08 (-45.85%)

04/15/19
CANT
04/15/19
NO CHANGE
Target $20
CANT
Overweight
Genfit data show CymaBay may be differentiated, says Cantor Fitzgerald
Further competitor primary biliary cholangitis data from Genfit's (GNFTF) elafibranor suggest CymaBay Therapeutics' (CBAY) seladelpar may have a differentiated profile, Cantor Fitzgerald analyst Eliana Merle tells investors in a research note. The analyst keeps an Overweight rating on CymaBay with a $20 price target.
05/14/19
SBSH
05/14/19
INITIATION
Target $21
SBSH
Buy
CymaBay initiated with a Buy at Citi
Citi analyst Joel Beatty started CymaBay Therapeutics (CBAY) with a Buy rating and $21 price target. The analyst believes the company's seladelpar will "likely dethrone" Intercept Pharmaceuticals' (ICPT) Ocaliva as the top-selling branded primary biliary cholangitis drug. Topline results for seladelpar in PBC are anticipated in 2021 and the analyst sees a 75% probability of approval.
06/07/19
LEER
06/07/19
NO CHANGE
Target $22
LEER
Outperform
FDA news has 'nothing to do' with CymaBay's programs, says SVB Leerink
SVB Leerink analyst Pasha Sarraf says that CymaBay Therapeutics is down on an "overreaction" to the FDA's recommendation regarding endpoint for compensated cirrhosis. In a research note to investors , Sarraf says he recommends purchasing at these levels, saying he continues to believe the the stock is likely to pop on the interim results from the MRI-PDFF results, which have not yet been announced and feels the FDA's announcement regarding compensated cirrhosis has "absolutely nothing to do" with CymaBay's programs. Sarraf has an Outperform rating and $22 price target on CymaBay shares.
06/11/19
PIPR
06/11/19
NO CHANGE
Target $8
PIPR
Overweight
Piper cuts CymaBay price target to $8 on 'worst case' results for NASH trial
Piper Jaffray analyst Tyler Van Buren said he did not anticipate that placebo would perform better than seladelpar in CymaBay Therapeutics' (CBAY) Phase 2b study of the drug for the treatment of nonalcoholic steatohepatitis. Calling the NASH trial results a "worst case scenario," Van Buren sees significant risk to the final 52-week data read-out and removed all expectations in NASH from his model. He said the data make seladelpar seem similar to Genfit's (GNFT) elafibranor, though seladelpar has not yet shown improvements in good cholesterol, glucose homeostatis, or insulin resistance. While Van Buren cut his price target on CymaBay shares to $8 from $30 based on the trial results, he keeps an Overweight rating on the shares given the sharp pullback this morning and the support he sees from the company's remaining cash and residual opportunity.

TODAY'S FREE FLY STORIES

HXL

Hexcel

$78.42

(0.00%)

05:12
06/24/19
06/24
05:12
06/24/19
05:12
Hot Stocks
Hexcel announces voluntary delisting from Euronext Paris »

Hexcel announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

EVA

Enviva

$29.50

-0.24 (-0.81%)

05:11
06/24/19
06/24
05:11
06/24/19
05:11
Upgrade
Enviva rating change  »

Enviva upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSI

Motorola Solutions

$165.16

-1.8 (-1.08%)

05:10
06/24/19
06/24
05:10
06/24/19
05:10
Hot Stocks
Motorola Solutions awarded tender for supplying POC service to Israel Railways »

Motorola Solutions has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 19

    Dec

CNTY

Century Casinos

$9.83

-0.3 (-2.96%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Century Casinos management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

CNCE

Concert Pharmaceuticals

$10.90

-0.165 (-1.49%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Concert Pharmaceuticals management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

ATH

Athene Holding

$42.58

-0.8 (-1.84%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Athene Holding management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

SSTI

ShotSpotter

$44.50

0.19 (0.43%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
ShotSpotter management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

ATH

Athene Holding

$42.58

-0.8 (-1.84%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Athene Holding management to meet with Sandler ONeill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

HUBG

Hub Group

$40.70

-1.25 (-2.98%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Hub Group management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

  • 13

    Nov

SPOT

Spotify

$148.17

-1.57 (-1.05%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Spotify management to meet with SunTrust »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

INGN

Inogen

$71.29

-1.37 (-1.89%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
William Blair medical tech analyst to hold a luncheon »

Medical Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 26

    Aug

STXB

Spirit of Texas Bancshares

$22.49

0.07 (0.31%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Spirit of Texas Bancshares management to meet with Sandler ONeill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

04:55
06/24/19
06/24
04:55
06/24/19
04:55
General news
Dallas Fed Mfg Survey General Activity Index to be reported at 10:30 »

June Dallas Fed Mfg…

04:55
06/24/19
06/24
04:55
06/24/19
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

INWK

InnerWorkings

$4.17

(0.00%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
InnerWorkings management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

OKTA

Okta

$130.77

-2.63 (-1.97%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Okta management to meet with KeyBanc »

Dinner Meeting with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

STFC

State Auto Financial

$34.64

-0.18 (-0.52%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
State Auto Financial management to meet with Sandler O'Neill »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

ABT

Abbott

$85.04

0.07 (0.08%)

, EVTCY

Evotec

$0.00

(0.00%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
American Society for Microbiology to hold a conference »

ASM Microbe 2019 will be…

ABT

Abbott

$85.04

0.07 (0.08%)

EVTCY

Evotec

$0.00

(0.00%)

WTKWY

Wolters Kluwer

$0.00

(0.00%)

TTPH

Tetraphase

$0.63

-0.02 (-3.10%)

PRTK

Paratek Pharmaceuticals

$3.77

(0.00%)

TMO

Thermo Fisher

$294.45

1.06 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 02

    Dec

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
JPMorgan U.S. energy team to hold an analyst/industry conference call »

U.S. Energy Analyst…

SCS

Steelcase

$15.46

-0.32 (-2.03%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Steelcase management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 26

    Jun

  • 10

    Jul

04:55
06/24/19
06/24
04:55
06/24/19
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

CLF

Cleveland-Cliffs

$10.04

-0.21 (-2.05%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Cleveland-Cliffs management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

ENS

EnerSys

$65.77

0.4003 (0.61%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
EnerSys management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

GES

Guess

$14.88

0.27 (1.85%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Guess management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

JWN

Nordstrom

$33.43

0.22 (0.66%)

04:55
06/24/19
06/24
04:55
06/24/19
04:55
Conference/Events
Nordstrom management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.